Categories Earnings, LATEST, Other Industries

Office Depot posts Q2 earnings of 5 cents vs expectation of 3 cents

Office Depot (ODP) Tuesday reported second-quarter results that surpassed analysts’ estimate on both the top and bottom lines. During the quarter, the company’s net income from continuing operations fell to $19 million, or $0.03 per share, compared to $21 million and $0.04 per share a year ago. Excluding items, the company earned $0.05 a share, above the consensus estimate of $0.03 a share.

Office Depot shares gained over 1% during pre-market trading.

Courtesy – Wikimedia Commons

The year-over-year decrease in the earnings was mainly due to lower gross margins from store and supply chain cost deleverage, as well as higher expenses experienced primarily in Q1 2018.

Sales during the quarter rose 11% to $2.6 billion. Analysts had expected $2.58 billion. The company reported a marginal growth of 1% in its product sales, while service revenues soared 120% helped by CompuCom acquisition. Services represent approximately 16% of total company sales.

Business Solutions Division reported a 4% growth in its sales to $1.3 billion, riding on the recent acquisitions and eCommerce growth. Meanwhile, sales of the retail division dipped 5% to $1.1 billion, partially impacted by the adoption of the new revenue recognition standard.

During the quarter, the company closed two stores and ended the quarter with a total of 1,374 stores in the Retail Division.

During the quarter the company said it paid a quarterly cash dividend of $0.025 per share on June 15 to its shareholders.

Most Popular

United Parcel Service (UPS) seems on track to regain lost strength

Cargo giant United Parcel Service, Inc. (NYSE: UPS) ended fiscal 2023 on a weak note, reporting lower revenues and profit for the fourth quarter. The company experienced a slowdown post-pandemic

IPO Alert: What to look for when Boundless Bio goes public

Boundless Bio is preparing to debut on the Nasdaq stock market this week, and become the latest addition to the list of biotech firms that have launched IPOs this year.

Nike (NKE) bets on innovation and partnerships to return to high growth

Sneaker giant Nike, Inc. (NYSE: NKE) has been going through a rough patch for some time, with sales coming under pressure from weak demand and rising competition. Post-pandemic, the company

Tags

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top